Protein kinase C β inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension

Diabetes

Volumn 52, Issue 2, 2003, Pages 512-518

  Kelly, Darren J ^a   Zhang, Yuan ^a   Hepper, Claire ^a   Gow, Renae M ^a   Jaworski, Kassie ^a   Kemp, Bruce E ^b   Wilkinson Berka, Jennifer L ^a   Gilbert, Richard E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C BETA; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME INHIBITION; HYPERGLYCEMIA; HYPERTENSION; IMMUNOFLUORESCENCE; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STRUCTURAL GENE;

ALBUMINURIA; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; ENZYME INHIBITORS; FEMALE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INDOLES; KIDNEY; KIDNEY GLOMERULUS; MALEIMIDES; ORGAN SIZE; PROTEIN KINASE C; RATS; RATS, MUTANT STRAINS; REFERENCE VALUES;

EID: 0037315791     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.2.512     Document Type: Article

References (44)

1. Ritz E, Rychlik I, Locatelli F, Halimi S: End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795-808, 1999
2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69-75, 1998
4. Parving H-H, Andersen ER, Smidt U, Hommel E, Mathiesen E: Antihypertensive treatment postpones endstage renal failure in diabetic nephropathy. Br Med J 294:1443-1447, 1987
5. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J: Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36:646-61, 2000
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
7. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I: Renoprotective effect of the angiotensinreceptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-60, 2001
8. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
9. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
10. Gruden G, Thomas S, Burt D, Lane S, Chusney G, Sacks S, Viberti G: Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction. Proc Natl Acad Sci U S A 94:12112-12116, 1997
11. Osicka TM, Yu Y, Panagiotopoulos S, Clavant SP, Kiriazis Z, Pike RN, Pratt LM, Russo LM, Kemp BE, Comper WD, Jerums G: Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes 49:87-93, 2000
12. Weiss RH, Ramirez A: TGF-beta- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C. Nephrol Dial Transplant 13:2804-2813, 1998
13. Kreisberg JI, Kreisberg SH: High glucose activates protein kinase C and stimulates fibronectin gene expression by enhancing a cAMP response element. Kidney Int Suppl 51:S3-S11, 1995
14. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest 83:1667-1675, 1989
15. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
16. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14:439-447, 2000
17. Anderson S: Role of local and systemic angiotensin in diabetic renal disease. Kidney Int 52 (Suppl. 63):S107-S110, 1997
18. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56:1627-1637, 1999
19. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541-544, 1990
20. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat. Kidney Int 54:343-352, 1998
21. Bunag RD: Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34:279-282, 1973
22. Jerums G, Allen TJ, Cooper ME: Triphasic changes in selectivity with increasing proteinuria in type I and type II diabetes. Diabet Med 6:772-779, 1989
23. Masson P: Trichrome stainings and their preliminary technique. J Tech Methods 2:75-90, 1929
24. Scholey JW, Miller PL, Rennke HG, Meyer TW: Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy. Kidney Int 36:816-822, 1989
25. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM: Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45:1559-1565, 1997
26. Lehr HA, van der Loos CM, Teeling P, Gown AM: Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem 47:119-126, 1999
27. Stratton IM, Adler AI, Nell HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000
28. Gilbert RE, Tsalamandris C, Bach L, Panagiotopoulos S, O'Brien RC, Allen TJ, Goodall I, Seeman E, Cooper ME, Murray R, Jerums G: Glycemic control and the rate of progression of early diabetic kidney disease. Kidney Int 44:855-859, 1993
29. Newton AC: Protein kinase C: structure, function, and regulation. J Biol Chem 270:28495-28498, 1995
30. Koya D, Jirousek MR, You-Wei L, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the giomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
31. Feng X, Zhang J, Barak LS, Meyer T, Caron MG, Hannun YA: Visualization of dynamic trafficking of a protein kinase C βII/green fluorescent protein conjugate reveals differences in G protein-coupled receptor activation and desensitization. J Biol Chem 273:10755-10762, 1998
32. Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, Wilkinson-Berka JL: Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (nLRen-2)27 rat. Kidney Int 57:1882-1894, 2000
33. Bader R, Bader E, Grung KE, Markensen-Haen S, Christ H, Bohle A: Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol Res Pract 167:204-216, 1980
34. Lane P, Steffes MW, Fioretto P, Mauer SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 43:661-667, 1993
35. Gilbert RE, Cox A, Wu LL, Allen TJ, Hulthen L, Jerums G, Cooper ME: Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of angiotensin converting enzyme inhibition. Diabetes 47:414-422, 1998
36. Kelly DJ, Gilbert RE, Cox AJ, Soulis T, Jerums GT, Cooper ME: Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy. J Am Soc Nephrol 12:2098-2107, 2001
37. Cordonnier DJ, Pinel N, Barro C, Maynard C, Zaoui P, Halimi S, De Ligny BH, Reznic Y, Simon D, Bilous RW: Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. J Am Soc Nephrol 10:1253-1263, 1999
38. Kriz W, Hosser H, Hahnel B, Gretz N, Provoost AP: From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies. Nephrol Dial Transplant 13:2781-2798, 1998
39. Murphy M, McGinty A, Godson C: Protein kinases C: potential targets for intervention in diabetic nephropathy. Curr Opin Nephrol Hypertens 7:563-570, 1998
40. Ganz MB, Abunader R, Saxena R, Grond J: Protein kinase C β(Ii) isoform is up-regulated in human proliferative glomerulonephritis. Exp Nephrol 5:225-232, 1997
41. Kang N, Alexander G, Park JK, Maasch C, Buchwalow I, Luft FC, Haller H: Differential expression of protein kinase C isoforms in streptozotocininduced diabetic rats. Kidney Int 56:1737-1750, 1999
42. Craven PA, Studer RK, Negrete H, DeRubertis FR: Protein kinase C in diabetic nephropathy. J Diabetes Complications 9:241-245, 1995
43. Kapor-Drezgic J, Zhou X, Babazono T, Dlugosz JA, Hohman T, Whiteside C: Effect of high glucose on mesangial cell protein kinase C-delta and -epsilon is polyol pathway-dependent. J Am Soc Nephrol 10:1193-1203, 1999
44. Banan A, Fields JZ, Farhadi A, Talmage DA, Zhang L, Keshavarzian A: The β1 isoform of protein kinase c mediates the protective effects of epidermal growth factor on the dynamic assembly of F-actin cytoskeleton and normalization of calcium homeostasis in human colonic cells. J Pharmacol Exp Ther 301:852-866, 2002